is liraglutide generic now
Prescription Weight Loss - 2019 Saxenda Beats 2024 Hype?
In 2019, Saxenda’s FDA approval delivered a 6.5% average weight loss, a benchmark that still competes with 2024 hype around newer GLP-1 drugs. The approval of liraglutide for chronic weight management created a regulatory pathway that opened the door for a wave of prescription weight-loss options. While Mounjaro